Tudor Investment Corp ET AL Trims Stake in Chemed Corporation $CHE

Tudor Investment Corp ET AL cut its stake in shares of Chemed Corporation (NYSE:CHE) by 81.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,106 shares of the company’s stock after selling 4,952 shares during the quarter. Tudor Investment Corp ET AL’s holdings in Chemed were worth $495,000 at the end of the most recent reporting period.

Other institutional investors have also modified their holdings of the company. Smartleaf Asset Management LLC increased its holdings in Chemed by 71.4% during the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after buying an additional 25 shares during the period. First Horizon Corp acquired a new stake in shares of Chemed during the third quarter worth $31,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Chemed during the third quarter worth $45,000. HM Payson & Co. lifted its stake in shares of Chemed by 35.5% during the third quarter. HM Payson & Co. now owns 103 shares of the company’s stock worth $46,000 after buying an additional 27 shares during the period. Finally, Geneos Wealth Management Inc. lifted its stake in shares of Chemed by 330.4% during the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after buying an additional 76 shares during the period. 95.85% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Oppenheimer cut their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Weiss Ratings cut shares of Chemed from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday. Royal Bank Of Canada restated a “sector perform” rating and issued a $422.00 price objective (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Finally, Zacks Research downgraded shares of Chemed from a “hold” rating to a “strong sell” rating in a research report on Wednesday, March 4th. Two analysts have rated the stock with a Buy rating, two have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and an average price target of $498.00.

Chemed Stock Up 0.4%

Chemed stock opened at $377.75 on Thursday. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $593.80. The firm has a fifty day moving average of $413.08 and a 200-day moving average of $428.97. The firm has a market capitalization of $5.52 billion, a P/E ratio of 20.56, a PEG ratio of 1.49 and a beta of 0.49.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 EPS for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). The company had revenue of $639.34 million for the quarter, compared to the consensus estimate of $659.09 million. Chemed had a net margin of 10.48% and a return on equity of 25.66%. The company’s revenue was down .1% compared to the same quarter last year. During the same quarter last year, the company earned $6.83 earnings per share. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, research analysts expect that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Monday, February 23rd were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a dividend yield of 0.6%. The ex-dividend date was Monday, February 23rd. Chemed’s dividend payout ratio (DPR) is currently 13.06%.

Insider Activity at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $403.18, for a total transaction of $806,360.00. Following the transaction, the chief executive officer owned 93,719 shares of the company’s stock, valued at approximately $37,785,626.42. This trade represents a 2.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 3.29% of the company’s stock.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.